Taal:
Valuta:
0 ARTIKELEN - $0.00 Bonus: 2
Generic Triumeq (Abacavir/dolutegravir/lamivudine)
Triumeq
Triumeq is a combination oral antiretroviral medication used to treat HIV-1 infection by preventing viral replication and reducing viral load.
Selecteer Doses: 600/50/300mg
600/50/300mg
30pillen
Triumeq $388.79
$323.99
$10.80 per pil
+ Free trackable courier service
+ pakketbezorgingsverzekering
+ Bij volgende bestellingen ontvang je een korting van 10%.
Toevoegen aan winkelwagentje
bespaar: $0.00
600/50/300mg
60pillen
Triumeq $680.39
$566.99
$9.45 per pil
+ Free trackable courier service
+ pakketbezorgingsverzekering
+ Bij volgende bestellingen ontvang je een korting van 10%.
Toevoegen aan winkelwagentje
bespaar: $81.00
600/50/300mg
90pillen
Triumeq $993.59
$827.99
$9.20 per pil
+ Free trackable courier service
+ pakketbezorgingsverzekering
+ Bij volgende bestellingen ontvang je een korting van 10%.
Toevoegen aan winkelwagentje
bespaar: $144.00
Package Example
Je bestelling wordt veilig verpakt en binnen 24 uur verzonden. Dit is precies hoe je pakket eruit zal zien (foto's van een echt verzendstuk). Het heeft de afmetingen en het uiterlijk van een gewone particuliere brief (9,4x4,3x0,3 inch of 24x11x0,7 cm) en geeft de inhoud niet prijs
Levertijd
Levering 14-21 dagen 10$ Tracking# beschikbaar in 4 dagen
Gratis standaard luchtpost voor alle bestellingen met een bedrag vanaf $200
Levering 5-9 dagen 30$ Tracking# beschikbaar in 2 dagen
Gratis traceerbare koeriersdienst voor alle bestellingen vanaf $300
Wereldwijde verzending Vertrouwelijkheid en anonimiteit gegarandeerd
Veilig en zeker Discreet looking packages
Bestellingen worden binnen 24 uur verzonden 100% succesvolle levering
Getuigenissen Productbeschrijving
Er is op dit moment geen beoordeling voor dit product, maar je kunt de eerste zijn om iets toe te voegen of je kunt meer lezen in Testimonials over gerelateerde producten.

Beoordeling Toevoegen

Common use

Triumeq combines abacavir, dolutegravir, and lamivudine to treat HIV-1 infection in adults and children. Abacavir and lamivudine are nucleoside reverse transcriptase inhibitors (NRTIs) that block viral DNA formation, while dolutegravir is an integrase inhibitor that prevents the virus from integrating into human DNA. Together, they help control viral replication and maintain immune function.

Dosage and direction

Triumeq is taken orally, usually once daily with or without food. Swallow tablets whole; do not crush or chew. Dosage may vary based on age, weight, kidney function, and previous HIV treatment. Regular monitoring of viral load, liver, and kidney function is recommended.

Precautions

Inform your doctor if you have liver or kidney problems, a history of lactic acidosis, heart disease, or if you carry the HLA-B*5701 gene, which increases the risk of abacavir hypersensitivity. Do not stop therapy abruptly, as it may cause viral rebound.

Contraindications

Do not use Triumeq if allergic to abacavir, dolutegravir, lamivudine, or any component of the tablet. It is contraindicated in patients with prior abacavir hypersensitivity.

Possible side effect

Common side effects include headache, nausea, diarrhea, fatigue, and insomnia. Serious side effects may include severe hypersensitivity reactions, liver toxicity, lactic acidosis, or immune reconstitution syndrome. Seek medical attention if severe symptoms occur.

Drug interaction

Triumeq may interact with certain anticonvulsants, rifampin, metformin, and other medications affecting liver enzymes or kidney function. Inform your doctor of all prescription drugs, over-the-counter products, and supplements you are taking.

Missed dose

If a dose is missed, take it as soon as possible. If it is near the time of the next dose, skip the missed dose. Do not take two doses at once.

Overdose

Overdose may cause severe nausea, vomiting, or dizziness. Seek immediate medical attention if overdose is suspected.

Storage

Store Triumeq at room temperature, away from moisture, heat, and light. Keep tablets in the original container and out of reach of children.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.

Getuigenissen
Jerry, 57, Munich
“We were at the edge of divorce when I decided to try this. Years and years without delight of orgasm and sexual satisfaction. This could ruin any life but not ours. Viagra worked and I always keep the pill near my bed as nobody knows when my wife asks ...
David, Bridlington
“I did not want to confess my sexual fail and intimacy problems. After taking it my penis worked as a paving breaker and my wife had no reason to complain during whole night. We hooked on it and purchase with a discount.”
Johnny,34
Ondanks dat dit mijn eerste online bestelling was en ik lang heb geaarzeld om met een creditcard via de site te betalen, heb ik het risico genomen en ontvangen wat ik bestelde. Het spreekt voor zich dat het product echt was en aankwam op het moment dat ...
Meer lezen...

Verzendoptie

Veilig Betalingsproces
Nieuws
Women with PMOS should have yearly NHS checks, says health watchdog
Despite affecting millions of women in the UK, PMOS is still under-diagnosed and inconsistently managed, say experts.
'Normal birth drive' criticism removed from maternity report, expert claims
Dr Bill Kirkup says he resigned from a government-commissioned review into NHS maternity services over the omission.
Government promises to act on maternity care failings which 'shame our society'
An independent inquiry has found "unacceptable racism and discrimination" is affecting patient safety.
Resident doctors in England accept pay deal and end strikes
Doctors have been locked in a three-year dispute with the government, resulting in several rounds of strikes.